Ronald S Weinstein

Dr. Ronald S Weinstein

Department of Pathology, College of Medicine, Arizona Health Sciences Center, The University of Arizona, 1501 N. Campbell Avenue, Room 1156, PO Box 245105, Tucson, AZ 85724, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in The American Journal of Medicine
Verified
Journal Article
Closed access
RWRonald S Weinstein
Ronald S Weinstein
ALAna Maria Lopez
Ana Maria Lopez
BJBellal A. Joseph
Bellal A. Joseph
KEKristine A. Erps
Kristine A. Erps
MHMichael Holcomb
Michael Holcomb
EKElizabeth A. Krupinski
Elizabeth A. Krupinski

1 August 2009 in Human Pathology
Verified
Journal Article
Closed access
RWRonald S Weinstein
Ronald S Weinstein
AGAnna R. Graham
Anna R. Graham
LRLynne C. Richter
Lynne C. Richter
GBGail P. Barker
Gail P. Barker
EKElizabeth A. Krupinski
Elizabeth A. Krupinski
JGJohn R. Gilbertson
John R. Gilbertson

1 May 2018 in Medical Clinics of North America
Verified
Journal Article
Closed access
RWRonald S Weinstein
Ronald S Weinstein
EKElizabeth A. Krupinski
Elizabeth A. Krupinski
CDCharles R. Doarn
Charles R. Doarn

19 March 2012 in APMIS
Verified
Journal Article
Closed access
PDF file
RWRonald S Weinstein
Ronald S Weinstein
AGAnna R. Graham
Anna R. Graham
FLFangru Lian
Fangru Lian
BBBeth L. Braunhut
Beth L. Braunhut
GBGail R. Barker
Gail R. Barker
ABAchyut K. Bhattacharyya
Achyut K. Bhattacharyya

1 January 2019 in Journal of Pathology Informatics
Verified
Journal Article
Open access
PDF file
RWRonald S Weinstein
Ronald S Weinstein
MHMichael J. Holcomb
Michael J. Holcomb
EKElizabeth A. Krupinski
Elizabeth A. Krupinski
This narrative-based paper provides a first-person account of the early history of telepathology (1985–2000) by the field's inventor, Ronald S. Weinstein, M. D. During the 1980s, Dr. Weinstein, a Massachusetts General Hospital-trained pathologist, was director of the Central Pathology Laboratory (CPL) for the National Cancer Institute-funded National Bladder Cancer Project, located at Rush Medical College in Chicago, IL. The CPL did post therapy revalidations of surgical pathology and cytopathology diagnoses before outcomes of the completed clinical trials were published. The CPL reported that interobserver variability was invalidating inclusion of dozens of treated bladder cancer patients in published reports on treatment outcomes. This problem seemed ripe for a technology-assisted solution. In an effort to solve the interobserver variability problem, Dr. Weinstein devised a novel solution, dynamic-robotic telepathology, that would potentially enable CPL uropathologists to consult on distant uropathology cases in real-time before their assignment to urinary bladder cancer, tumor stage, and grade-specific clinical trials. During the same period, universities were ramping up their support for faculty entrepreneurism and creating in-house technology transfer organizations. Dr. Weinstein recognized telepathology as a potential growth industry. He and his sister, Beth Newburger, were a successful brother–sister entrepreneur team. Their PC-based education software business, OWLCAT™, had just been acquired by Digital Research Inc., a leading software company, located in California. With funding from the COMSAT Corporation, a publically traded satellite communications company, the Weinstein-Newburger team brought the earliest dynamic-robotic telepathology systems to market. Dynamic-robotic telepathology became a dominant telepathology technology in the late 1990s. Dr. Weinstein, a serial entrepreneur, continued to innovate and, with a team of optical scientists at The University of Arizona's College of Optical Sciences, developed the first sub-1-min whole-slide imaging system, the DMetrix DX-40 scanner, in the early 2000s.

1 January 2016 in Academic Pathology
Verified
Journal Article
Open access
EBErika Bracamonte
Erika Bracamonte
BGBlake A. Gibson
Blake A. Gibson
RKRobert Klein
Robert Klein
EKElizabeth A. Krupinski
Elizabeth A. Krupinski
RWRonald S Weinstein
Ronald S Weinstein
In order to document perceptions of text comments appearing in surgical pathology reports, questionnaires were distributed to 4 groups of caregivers: university staff pathologists, resident pathologists, faculty clinicians (other than pathologists), and resident clinicians at a teaching hospital. Results of this pilot study showed a wide degree of variability existed within each group of surgical pathology report users, with respect to percent confidence assigned to various phrases, commonly used to express diagnostic uncertainty, appearing often as free-text comments in surgical pathology reports. The unavailability of immunohistochemistry tests, or ambiguous immunohistochemistry test results, was especially problematic. With respect to modes of communication between the surgical pathology laboratory and its service users, clinicians indicated they preferred to use tumor boards/interdisciplinary conferences, face-to-face meetings, and phone calls to clarify their interpretations of a pathologist’s diagnoses, as compared with simply reading free-text comments. On the other hand, surgical pathologists rely heavily on their use of the comment portion of a surgical pathology report to clarify, modify, or expand on the diagnoses they render. The majority of clinicians stated that they “always” read the free-text comment portion of a surgical pathology report, whereas some acknowledged they do not always read it. Pathology residents had significantly less confidence in the ability of a free-text comment on a surgical pathology report to clarify a diagnosis (χ2 = 46.36, P < .0001). Pathology departments should consider standardizing definitions and weighting the words and phrases they use in their free-text comment sections of surgical pathology reports.